Red Lake Nation News - Babaamaajimowinan (Telling of news in different places)

Omicron may sideline two leading drugs against COVID-19

 

December 20, 2021

Frank Augstein, Associated Press

Shoppers rush along Oxford Street, Europe's busiest shopping street, in London, Saturday, Dec. 18, 2021.

WASHINGTON - As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they've used to fight infections are unlikely to work against the new strain.

For more than a year antibody drugs from Regeneron and Eli Lilly have been the go-to treatments for early COVID-19, thanks to their ability to head off severe disease and keep patients out of the hospital.

But both drugmakers recently warned that laboratory testing suggests their therapies will be much less potent against omicron, which contains dozens of mutations that make it harder for antibodies to attack the virus. And while the companies say they can quickly develop new omicron-targeting antibodies, those aren't expected to launch for at least several months.

https://www.startribune.com/omicron-may-sideline-two-leading-drugs-against-covid-19/600128592/

 

Reader Comments(0)

 
 

Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2021